$ARWR Recent Headlines Six stocks to watch 1:47 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Oct 3, 2014 at 12:34 PM

$ARWR Recent Headlines

Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
Nasdaq breaks out, S&P 500 takes flight 11:37 a.m. June 6, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:53 p.m. March 11, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:40 p.m. March 11, 2014 - Michael Ashbaugh
U.S. benchmarks rattle the cage on major resistance 1:16 p.m. Feb. 7, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
A 6-pack of hedge fund moves to take note of 12:08 p.m. Oct. 21, 2013 - Insider Monkey
Six stocks poised to move higher 3:23 p.m. Oct. 2, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:00 p.m. Sept. 26, 2013 - The Trading Deck
Arrowhead reports positive data on hep B drug 2:10 p.m. Feb. 26, 2013 - MarketWatch.com
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:12 p.m. Aug. 13, 2012 - MarketWatch

Ocera Therapeutics Finally Ready To Reward Investors 12:32 p.m. Oct. 1, 2014 - Seeking Alpha
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Sept. 12, 2014 - Seeking Alpha
3 Biotech Breakout Charts That Could See More Upside 1:47 p.m. Sept. 11, 2014 - TheStreet.com
Arrowhead Research Corp Heads Higher After Breakout 1:51 p.m. Sept. 4, 2014 - benzinga.com
Strong On High Volume: Arrowhead Research (ARWR) 10:06 a.m. Sept. 4, 2014 - TheStreet.com
Arrowhead Research Climbs +8.54% Midday, Is Up Over +50% YTD 1:41 p.m. Sept. 3, 2014 - TheStreet.com
Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues 11:54 a.m. Sept. 3, 2014 - benzinga.com
5 Red-Hot Biotech Stocks 1:14 a.m. Aug. 19, 2014 - InvestorPlace.com
Stock To Watch: Arrowhead Research (ARWR) In Perilous Reversal 11:40 a.m. Aug. 15, 2014 - TheStreet.com
Cramer's Lightning Round - I'm Not Touching Potbelly (8/13/14) 6:25 a.m. Aug. 14, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Don't Buy IBM Right Now 6:00 a.m. Aug. 14, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Now That's More Like It 8:25 p.m. Aug. 13, 2014 - TheStreet.com
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day 3:06 a.m. Aug. 13, 2014 - Zacks.com
Arrowhead's (ARWR) CEO Dr. Christopher Anzalone on Q3 2014 Results - Earnings Call Transcript 10:29 p.m. Aug. 12, 2014 - Seeking Alpha
Arrowhead Discloses First Human Hepatitis B Therapy Results 5:11 p.m. Aug. 12, 2014 - TheStreet.com
Arrowhead Research (ARWR) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: ARROWHEAD RESEARCH CORP 4:03 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Has The Tekmira Pharmaceuticals Ebola Trade Run Its Course? 11:54 a.m. Aug. 5, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) 9:55 a.m. Aug. 4, 2014 - TheStreet.com

Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs 7:31 a.m. Sept. 30, 2014 - BusinessWire - BZX
Arrowhead to Present at BioCentury’s NewsMakers in the Biotech Industry Conference 2:00 p.m. Sept. 19, 2014 - BusinessWire - BZX
Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver 9:31 a.m. Aug. 27, 2014 - PR Newswire - PRF
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 5:02 p.m. Aug. 12, 2014 - BusinessWire - BZX
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results 4:08 p.m. July 31, 2014 - BusinessWire - BZX
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 8:40 a.m. July 18, 2014 - PR Newswire - PRF
Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne 5:50 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Arrowhead Research Set to Join Russell 3000 Index 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520 5:41 p.m. June 13, 2014 - BusinessWire - BZX
Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate 4:05 p.m. June 11, 2014 - BusinessWire - BZX
Arrowhead to Present at Upcoming Investor Conferences 4:05 p.m. June 10, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...